tiprankstipranks
China NT Pharma Group Co., Ltd. (HK:1011)
:1011
Hong Kong Market

China NT Pharma Group Co., Ltd. (1011) Income Statement

Compare
1 Followers

China NT Pharma Group Co., Ltd. Income Statement

Last quarter (Q2 2024), China NT Pharma Group Co., Ltd.'s total revenue was ¥31.30M, a decrease of -72.90% from the same quarter last year. In Q2, China NT Pharma Group Co., Ltd.'s net income was ¥661.00K. See China NT Pharma Group Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 7.37M¥ 207.09M¥ 226.70M¥ 221.73M¥ 365.97M
Gross Profit
¥ 7.37M¥ 125.29M¥ 145.46M¥ 134.90M¥ 260.88M
Operating Expenses
¥ 7.37M¥ 117.56M¥ 228.39M¥ 217.82M¥ 254.81M
Depreciation and Amortization
¥ 5.88M¥ 21.07M¥ 42.25M¥ 24.40M¥ 31.13M
EBITDA
¥ 1.33M¥ 10.39M¥ -17.78M¥ -43.74M¥ -155.97M
Operating Income
¥ 0.00¥ 18.44M¥ -59.28M¥ -68.13M¥ -22.05M
Other Income/Expenses
¥ -33.37M¥ -23.50M¥ -89.47M¥ -117.37M¥ -148.98M
Pretax Income
¥ -33.37M¥ -54.30M¥ -148.75M¥ -200.29M¥ -583.47M
Net Income
¥ -143.59M¥ -66.41M¥ -151.33M¥ -191.27M¥ -593.20M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -0.04¥ -0.04¥ -0.08¥ -0.10¥ -0.34
Diluted EPS
¥ -0.17¥ -0.04¥ -0.08¥ -0.10¥ -0.34
Weighted Average Shares Outstanding
848.12M 1.90B 1.89B 1.89B 1.76B
Weighted Average Shares Outstanding (Diluted)
197.82M 1.90B 1.89B 1.89B 1.76B
Currency in CNY

China NT Pharma Group Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis